Get latest articles and stories on India at LatestLY. RSV poses a significant global public health challenge, particularly affecting children, and stands as the second most common cause of death in infants under one year of age, following only malaria. India News | AstraZeneca India Gets CDSCO Approval for 'Palivizumab' Preventive Therapy Against Respiratory Syncytial Virus.
AstraZeneca Pharma India Receives CDSCO Approval for 'Palivizumab' Injection freepressjournal.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from freepressjournal.in Daily Mail and Mail on Sunday newspapers.
AstraZeneca India gets CDSCO approval for 'Palivizumab' preventive therapy against respiratory syncytial virus bignewsnetwork.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bignewsnetwork.com Daily Mail and Mail on Sunday newspapers.
AstraZeneca India gets CDSCO approval for 'Palivizumab' preventive therapy against respiratory syncytial virus calcuttanews.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from calcuttanews.net Daily Mail and Mail on Sunday newspapers.
AstraZeneca India gets CDSCO approval for 'Palivizumab' preventive therapy against respiratory syncytial virus webindia123.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from webindia123.com Daily Mail and Mail on Sunday newspapers.